As the carcinogenesis and progression of HNSCC are known to involve multiple genetic and epigenetic abnormalities, it is imperative to ascertain the effects of Bmi-1 targeting on normal cells. This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.